VIVACITY-MG: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACO-KINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF NIPOCALIMAB ADMINISTERED TO ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

被引：0

作者：

Antozzi, Carlo ^{[1
]}

Guptill, Jeffrey ^{[2
]}

Bril, Vera ^{[3
]}

Gamez, Josep ^{[4
]}

Meuth, Sven G. ^{[5
]}

Blanco, Jose L. M. ^{[6
]}

Nowak, Richard J. ^{[7
]}

Quan, Dianna ^{[8
]}

Sevilla, Teresa ^{[9
]}

Szczudlik, Andrzej ^{[10
]}

Hegarty, Brooke ^{[11
]}

Jouvin, Marie-Helene ^{[11
]}

Jin, Jim ^{[11
]}

Arroyo, Santiago ^{[11
]}

机构：

[1] Fdn Ist Neurol Carlo Besta, Milan, Italy

[2] Duke Univ, Sch Med, Durham, NC USA

[3] Univ Toronto, Div Neurol, Toronto, ON, Canada

[4] Hosp Univ Vall Hebron, Neuromuscular Unit, Barcelona, Spain

[5] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

[6] Hosp Gen Univ Gregorio Maranon, Serv Neurol, Madrid, Spain

[7] Yale Univ, Sch Med, New Haven, CT USA

[8] Univ Colorado, Sch Med, Aurora, CO USA

[9] Hosp Univ Politecn La Fe, Valencia, Spain

[10] Jagiellonian Univ, Med Coll, Krakow, Poland

[11] Momenta Pharmaceut, Cambridge, MA USA

来源：

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-119

引用

页码：498 / 498

页数：1

共 50 条

[31] A randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CBP-201 administered to healthy adult subjects
Royal, Mike A.
White, Jeffery
Snyder, Ben
Wei, Zheng
Pan, Wubin
Wang, Junying
Sansone, Kenneth J.
Yang, Xin
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB159 - AB159
[32] A PHASE 2, RANDOMIZED, DOUBLE- BLIND PLACEBO-CONTROLLED STUDY TO TEST THE EFFICACY AND SAFETY OF MAVRILIMUMAB IN GIANT CELL ARTERITIS: STUDY DESIGN AND METHODOLOGY
Pupim, Lara
Unizony, Sebastian
Cid, Maria
Pilipski, Lucas
Gandhi, Rohan
Pirrello, Joe
Ren, Ai
Fang, Fang
Martin, Dana
Paolini, John
RHEUMATOLOGY, 2019, 58
[33] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Patients with An Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Bateman, Lucinda
Spera, Allan
Palmer, Robert H.
Trugman, Joel M.
Lin, Jennifer
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S628 - S628
[34] A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia
Elhilali, MM
Ramsey, EW
Barkin, J
Casey, RW
Boake, RC
Beland, G
Fradet, Y
Trachtenberg, J
Orovan, WL
Schick, E
Klotz, LH
UROLOGY, 1996, 47 (03) : 335 - 342
[35] Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
Howard Jr, James F.
Bresch, Saskia
Genge, Angela
Hewamadduma, Channa
Hinton, John
Hussain, Yessar
Juntas-Morales, Raul
Kaminski, Henry J.
Maniaol, Angelina
Mantegazza, Renato
Masuda, Masayuki
Sivakumar, Kumaraswamy
Smilowski, Marek
Utsugisawa, Kimiaki
Vu, Tuan
Weiss, Michael
Zajda, Malgorzata
Boroojerdi, Babak
Brock, Melissa
de la Borderie, Guillemette
Duda, Petra W.
Lowcock, Romana
Vanderkelen, Mark
Leite, M. Isabel
LANCET NEUROLOGY, 2023, 22 (05): : 395 - 406
[36] Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Biedenbender, Rex
Bevilacqua, Joan
Gregg, Anne M.
Watson, Mike
Dayan, Gustavo
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (01): : 75 - 84
[37] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
You, Hong
Sun, Yameng
Wu, Cuisong
Xin, Guijie
Zhong, Bihui
Wu, Xiaofeng
Liu, Yali
Shi, Junping
Zhang, Qin
Zhao, Yingren
Gao, Yufeng
Xin, Yongning
Zhu, Yueyong
Wu, Lixian
Mao, Xiaorong
Du, Jian
Shang, Jia
Sun, Weiwei
Xu, Jie
Yu, Zujiang
Nan, Yuemin
Sheng, Huiping
Li, Yue
Rao, Huiying
Yu, Chaohui
Wu, Xiaoning
Tong, Xiaofei
HEPATOLOGY, 2024, 80 : S1969 - S1970
[38] A Phase 2/3 Placebo-Controlled, Parallel Group, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: the ARISE study
Ford, Lisa
Wong, Janice
Youssef, Eriene
Murray, Robert
Lim, Pilar
Nobile-Orazio, Eduardo
Merkies, Ingemar
Cornblath, David
Sun, Hong
NEUROLOGY, 2023, 100 (17)
[39] A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation
Xiao, Dan
Kotler, Mitchell
Kang, Jian
Wang, Chen
JOURNAL OF ADDICTION MEDICINE, 2020, 14 (01) : 69 - 77
[40] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Gupta, Pawan Kumar
Maheshwari, Sunil
Cherian, Joe Joseph
Goni, Vijay
Sharma, Arun Kumar
Tripathy, Sujith Kumar
Talari, Keerthi
Pandey, Vivek
Sancheti, Parag Kantilal
Singh, Saurabh
Verma, Nikhil N.
Kumar, Uday
AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266

← 1 2 3 4 5 →